Concizumab + Coagulation Factor Viia Recombinant Human Interaction

Majorinteraction on record

Description

High and/or frequent doses increase risk of thromboembolism. Additive and synergistic increase in thrombin peak observed with concomitant use.

Mechanism

Additive and synergistic increase in thrombin generation

Source: NLP:concizumab